Cited by 529T-cell and B-cell ImmunologyPsoriasis: Treatment and PathogenesisCytokine Signaling Pathways and Interactions

Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27–stimulated T cells

Fitzgerald, Denise C, Zhang, Guang-Xian, El-Behi, Mohamed, Fonseca-Kelly, Zoë, Li, Hongmei, Yu, Shuo, Saris, Christiaan J M, Gran, Bruno +2 more·2007·Nature Immunology

Abstract

Excessive inflammation occurs during infection and autoimmunity in mice lacking the alpha-subunit of the interleukin 27 (IL-27) receptor. The molecular mechanisms underlying this increased inflammation are incompletely understood. Here we report that IL-27 upregulated IL-10 in effector T cells that produced interferon-gamma and expressed the transcription factor T-bet but did not express the transcription factor Foxp3. These IFN-gamma+T-bet+Foxp3- cells resembled effector T cells that have been identified as the main source of host-protective IL-10 during inflammation. IL-27-induced production of IL-10 was associated with less secretion of IL-17, and exogenous IL-27 reduced the severity of adoptively transferred experimental autoimmune encephalomyelitis by a mechanism dependent on IL-10. Our data show that IL-27-induced production of IL-10 by effector T cells contributes to the immunomodulatory function of IL-27.

Integrity signals

Registry

Crossref · 10.1038/ni1540

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ustekinumab, an inhibitor of p40 targeting IL-23 and IL-12, was first shown to be efficacious in treating psoriasis.

    “After the identification of the IL-23/IL-17 axis as an important mediator of pathogenesis in preclinical models, ustekinumab, an inhibitor of p40 targeting both IL-23 and IL-12, was first shown to be efficacious in treating psoriasis [136].”

    From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [136]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fitzgerald, D. C., Zhang, G.-X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. M., Gran, B., Ciric, B., & Rostami, A.
Affiliations
  • Thomas Jefferson University (US)
  • Amgen (United States) (US)
Corresponding author
Rostami, Abdolmohamad
Venue
Nature Immunology
Published
2007-11-11
Volume
8
Issue
12
Pages
1372-1379
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
OpenAlex
W2067640086
Cited by
529
References
3
Citations by year
2026: 3 · 2025: 4 · 2024: 12 · 2023: 14 · 2022: 15 · 2021: 19 · 2020: 26 · 2019: 23 · 2018: 14 · 2017: 25 · 2016: 30 · 2015: 33 · 2014: 32 · 2013: 43 · 2012: 39
FWCI
18.31
Type
journal article
Language
en
Update notices
erratum (2008-01-01)
Open access
closed
Locations
  • Nature Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion)
Funders
  • National Institutes of Health (5r01ai061818-05)
  • National Institute of Allergy and Infectious Diseases (5R01AI061818)
  • National Institute of Neurological Disorders and Stroke (5R01NS0467892)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
IL-27, IL-10, experimental autoimmune encephalomyelitis, autoimmune inflammation, central nervous system autoimmunity, IL-27 receptor alpha, effector T cells, interferon-gamma, T-bet, Foxp3, IL-17, immunomodulation, adoptive transfer
MeSH terms
Animals, Central Nervous System Diseases, Encephalomyelitis, Autoimmune, Experimental, Inflammation, Lymphocyte Activation, T-Lymphocytes, Autoimmunity, Interleukin-10, Interleukin-17, T-Lymphocytes, Regulatory, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review